From: Irisin: a new molecular marker and target in metabolic disorder
Population | Group size | Study design | |
---|---|---|---|
Positive correlation between irisin levels and obesity | |||
Huh et al. [3] | Healthy middle-aged women with wide range of BMI | 117 | Cross-sectional |
Stengel et al. [4] | Anorexia nervosa patients, normal weight control subjects, and morbidly obese patients | 40 | Cross-sectional |
Pardo et al. [5] | Anorexia nervosa patients, normal weight control subjects, and morbidly obese patients | 145 | Cross-sectional |
Liu et al. [6] | Diabetic subjects and non-diabetic subjects | 156 | Cross-sectional |
Huh et al. [3] | Subjects undergoing gastric banding or gastric bypass surgery | 14 | Interventional |
De la Iglesia et al. [13] | Subjects following an 8-week hypocaloric dietary strategy | 93 | Interventional |
Crujeiras et al. [8] | Obese patients undergoing a weight loss program consisting of 8 weeks of a hypocaloric diet and follow-up at 16-weeks | 94 | Interventional |
Negative correlation between irisin levels and obesity | |||
Moreno-Navarrete et al. [10] | Non-diabetic subjects | 69 | Cross-sectional |
Choi et al. [11] | NGT subjects and new-onset T2DM subjects | 208 | Cross-sectional |